LUNG Stock Summary and Trading Ideas (Pulmonx | NASDAQ:LUNG)

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company;s revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, with the majority in the USA.

Pulmonx trades on the NASDAQ stock market under the symbol LUNG.

As of March 31, 2026, LUNG stock price climbed to $1.29 with 412,138 million shares trading.

LUNG has a beta of 1.00, meaning it tends to be less sensitive to market movements. LUNG has a correlation of 0.02 to the broad based SPY ETF.

LUNG has a market cap of $54.49 million. This is considered a Micro Cap stock.

Last quarter Pulmonx reported $23 million in Revenue and -$.25 earnings per share. This beat revenue expectation by $865,002 and exceeded earnings estimates by $.14.

In the last 3 years, LUNG traded as high as $14.84 and as low as $1.13.

The top ETF exchange traded funds that LUNG belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

LUNG has underperformed the market in the last year with a price return of -81.1% while the SPY ETF gained +18.4%. LUNG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -43.4% and -19.9%, respectively, while the SPY returned -5.1% and -2.5%, respectively.

LUNG support price is $1.10 and resistance is $1.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LUNG shares will trade within this expected range on the day.